Home » Topics » Deals and M&A » Collaboration

Collaboration
RSS

Proacta and Yakult Honsha enter PR-509 development agreement

Feb. 24, 2011

Vical and U.S. government extend collaboration to develop vaccines against emerging diseases

Feb. 24, 2011

Sanofi Pasteur and International Vaccine Institute join forces against dengue fever

Feb. 23, 2011

Omeros expands exclusive PDE7 inhibitor license from Daiichi Sankyo

Feb. 23, 2011

MedTrust Online and Avantra partner to validate cancer biomarker assays

Feb. 23, 2011

MorphoSys receives milestone payment from Novartis in connection with HuCAL technology

Feb. 22, 2011

Santhera regains rights to fipamezole from Biovail

Feb. 18, 2011

DPZ and Ascenion sign license agreement for recombinant VP1-containing VLP

Feb. 18, 2011

PharmaGap contracts NLI to develop liposomal GAP-107B8 formulation

Feb. 17, 2011

Astellas and Aveo sign agreement for tivozanib outside of Asia

Feb. 17, 2011

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 1, 2026.
TROP2 ADCs progress into first-line for lung, breast cancers
BioWorld
Multiple updates on TROP2-directed antibody-drug conjugates (ADCs) for lung and breast cancers highlight both progress made and opportunities for improvement for...
New evidence links autoimmunity to long COVID symptoms
BioWorld
Recent findings are reshaping current understanding of the post-infection landscape of SARS-CoV-2. Although previous studies had already suggested that...
Breakthrough as GSK’s bepirovirsen clears 19% of chronic hep B infections
BioWorld
GSK plc has announced a breakthrough in the treatment of chronic hepatitis B, reporting a functional cure rate of 19% across two phase III trials of its antisense...
BMS’ mezigdomide doubles PFS in multiple myeloma
BioWorld
Bristol Myers Squibb Co. disclosed in March 2026 that the phase III portion of the seamless phase II/III Successor-2 study testing mezigdomide in combination with...